Edward Charles HALL

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
2-azaspiro[3.4]octane derivatives as M4 agonists
- Patent number 12,122,761
- Issue date Oct 22, 2024
- Novartis AG
- Amy Calhoun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-azaspiro[3.4]octane derivatives as M4 agonists
- Patent number 11,820,778
- Issue date Nov 21, 2023
- Novartis AG
- Amy Calhoun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-azaspiro[3.4]octane derivatives as M4 agonists
- Patent number 11,548,865
- Issue date Jan 10, 2023
- Novartis AG
- Amy Calhoun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-azaspiro[3.4]octane derivatives as M4 agonists
- Patent number 11,485,742
- Issue date Nov 1, 2022
- Novartis AG
- Amy Calhoun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sustained delivery of angiopoetin-like 3 polypeptides
- Patent number 11,389,541
- Issue date Jul 19, 2022
- Novartis AG
- Christopher M. Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors
- Patent number 10,112,926
- Issue date Oct 30, 2018
- Novartis AG
- Benjamin Richard Bellenie
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
- Patent number 10,004,732
- Issue date Jun 26, 2018
- Novartis AG
- Benjamin Richard Bellenie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
- Publication number 20230212139
- Publication date Jul 6, 2023
- Novartis AG
- Amy CALHOUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED RELEASE DELIVERY SYSTEMS COMPRISING TRACELESS LINKERS
- Publication number 20230201353
- Publication date Jun 29, 2023
- Novartis AG
- Christopher M. ADAMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-AZASPIRO[3,4]OCTANE DERIVATIVES AS M4 AGONISTS
- Publication number 20220411435
- Publication date Dec 29, 2022
- Novartis AG
- Amy CALHOUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED DELIVERY OF ANGIOPOETIN-LIKE 3 POLYPEPTIDES
- Publication number 20220323595
- Publication date Oct 13, 2022
- Novartis AG
- Christopher M. ADAMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
- Publication number 20210130365
- Publication date May 6, 2021
- Novartis AG
- Amy CALHOUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
- Publication number 20210107889
- Publication date Apr 15, 2021
- Novartis AG
- Amy CALHOUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED DELIVERY OF ANGIOPOETIN-LIKE 3 POLYPEPTIDES
- Publication number 20200108153
- Publication date Apr 9, 2020
- Novartis AG
- Christopher M. ADAMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
- Publication number 20180243297
- Publication date Aug 30, 2018
- Novartis AG
- Benjamin Richard BELLENIE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AMINO PYRAZINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS
- Publication number 20170042889
- Publication date Feb 16, 2017
- Novartis AG
- Benjamin Richard BELLENIE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS
- Publication number 20170037032
- Publication date Feb 9, 2017
- Novartis AG
- Benjamin Richard BELLENIE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Edward Charles HALL

Person

Patents Grantslast 30 patents

2-azaspiro[3.4]octane derivatives as M4 agonists

2-azaspiro[3.4]octane derivatives as M4 agonists

2-azaspiro[3.4]octane derivatives as M4 agonists

2-azaspiro[3.4]octane derivatives as M4 agonists

Sustained delivery of angiopoetin-like 3 polypeptides

Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors

Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors

Patents Applicationslast 30 patents

2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS

SUSTAINED RELEASE DELIVERY SYSTEMS COMPRISING TRACELESS LINKERS

2-AZASPIRO[3,4]OCTANE DERIVATIVES AS M4 AGONISTS

SUSTAINED DELIVERY OF ANGIOPOETIN-LIKE 3 POLYPEPTIDES

2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS

2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS

SUSTAINED DELIVERY OF ANGIOPOETIN-LIKE 3 POLYPEPTIDES

Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors

AMINO PYRAZINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS

AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS